Objective: To investigate the effects of rosiglitazone, a synthetic ligand of peroxisome proliferators-activated receptor gamma (PPARγ), on the expression of a
World Health Organization (WHO) points out that medicine in 21st century will develop from "emphasis on treatment" to "emphasis on prevention" and will develop